JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB2072

Anti-Amyloid Precursor Protein antibody

4

(4 Reviews)

|

(23 Publications)

Rabbit Polyclonal Amyloid-beta precursor protein antibody. Suitable for WB, IHC-P and reacts with Rat, Mouse, Human samples. Cited in 23 publications. Immunogen corresponding to Synthetic Peptide within Human APP aa 650-700.

View Alternative Names

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Amyloid Precursor Protein antibody (AB2072)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Amyloid Precursor Protein antibody (AB2072)

Human brain tissue stained for Amyloid Precursor Protein using ab2072 at 2.5 μg/ml in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Amyloid Precursor Protein antibody (AB2072)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Amyloid Precursor Protein antibody (AB2072)

Rat heart tissue stained for Amyloid Precursor Protein using ab2072 at 20 μg/ml in immunohistochemical analysis.

Western blot - Anti-Amyloid Precursor Protein antibody (AB2072)
  • WB

Supplier Data

Western blot - Anti-Amyloid Precursor Protein antibody (AB2072)

All lanes:

Western blot - Anti-Amyloid Precursor Protein antibody (ab2072) at 1 µg/mL

Lane 1:

Human brain tissue lysate

Lane 2:

Mouse brain tissue lysate

Lane 3:

Rat brain tissue lysate

Predicted band size: 86 kDa

false

Western blot - Anti-Amyloid Precursor Protein antibody (AB2072)
  • WB

Supplier Data

Western blot - Anti-Amyloid Precursor Protein antibody (AB2072)

1 h incubation at RT in 5% NFDM/TBST

All lanes:

Western blot - Anti-Amyloid Precursor Protein antibody (ab2072) at 0.5 µg/mL

Lane 1:

WT 293T Cells at 10 µg

Lane 2:

APP knockout 293T Cells at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 86 kDa

false

Western blot - Anti-Amyloid Precursor Protein antibody (AB2072)
  • WB

Supplier Data

Western blot - Anti-Amyloid Precursor Protein antibody (AB2072)

1 h incubation at RT in 5% NFDM/TBST.

All lanes:

Western blot - Anti-Amyloid Precursor Protein antibody (ab2072) at 0.5 µg/mL

Lane 1:

Wild type 293T cells at 10 µg

Lane 2:

APP knockout 293T cells at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 86 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P

applications

Immunogen

Synthetic Peptide within Human APP aa 650-700. The exact immunogen used to generate this antibody is proprietary information.

P05067

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "10 µg/mL", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "10 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
A few months
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Amyloid Precursor Protein (APP) also known as amyloid protein is a transmembrane protein that is approximately 695 to 770 amino acids in length depending on the isoform. The molecular mass of APP can vary but typically falls around 100 to 140 kDa. It is heavily expressed in the central nervous system particularly in neurons but also in other tissues like muscle and kidney. The APP undergoes proteolytic processing which leads to the generation of various fragments including beta-amyloid peptides.
Biological function summary

The processing of APP plays a fundamental role in neuronal growth survival and repair. APP is cleaved into fragments that can regulate synaptic function and plasticity. It does not operate as a part of a complex but interacts with various cellular components. The protein participates in signaling pathways influencing cellular adhesion motility and neurite outgrowth. APP’s numerous interaction partners facilitate its involvement in different cellular processes highlighting its critical role in normal cell function.

Pathways

The APP is a central component in the amyloidogenic pathway where its cleavage by beta-secretase and gamma-secretase yields beta-amyloid. This pathway is one of two primary metabolic routes for APP—alternative enzymatic processing through the non-amyloidogenic pathway precludes beta-amyloid formation releasing peptides that do not aggregate. Enzymes like BACE1 (beta-secretase 1) and presenilin are important in the amyloidogenic pathway directly resulting in the production of the neurotoxic amyloid beta-peptide.

APP is intensely linked to Alzheimer's disease and cerebral amyloid angiopathy. Accumulation of beta-amyloid peptides formed from APP cleavage is a hallmark of Alzheimer's disease leading to plaque formation in the brain. This aggregation impacts neuronal function and is associated with neurodegenerative processes. Interactions with proteins like tau are significant as tau also plays an essential role in Alzheimer's disease pathology. Misprocessing of APP and the resulting beta-amyloid aggregates are also contributors to cerebral amyloid angiopathy where deposits within cerebrovascular walls compromise vascular integrity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed : 25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed : 17062754, PubMed : 23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.. Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.. Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.. The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
See full target information APP

Publications (23)

Recent publications for all applications. Explore the full list and refine your search

Acta physiologica (Oxford, England) 240:e14142 PubMed38584589

2024

Amyloid precursor protein induces reactive astrogliosis.

Applications

Unspecified application

Species

Unspecified reactive species

Gretsen Velezmoro Jauregui,Dragana Vukić,Isaac G Onyango,Carlos Arias,Jan S Novotný,Kateřina Texlová,Shanshan Wang,Kristina Locker Kovačovicova,Natalie Polakova,Jana Zelinkova,Maria Čarna,Valentina Lacovich,Brian P Head,Daniel Havas,Martin Mistrik,Robert Zorec,Alexei Verkhratsky,Liam Keegan,Mary A O'Connell,Robert Rissman,Gorazd B Stokin

Basic and clinical neuroscience 14:203-212 PubMed38107528

2023

Investigation of the Iron Oxide Nanoparticle Effects on Amyloid Precursor Protein Processing in Hippocampal Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Leila Sadeghi,Arezu Marefat

British journal of pharmacology 179:1769-1783 PubMed34820835

2022

A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.

Applications

Unspecified application

Species

Unspecified reactive species

Khaled S Abd-Elrahman,Shaarika Sarasija,Tash-Lynn L Colson,Stephen S G Ferguson

Scientific reports 10:20044 PubMed33208877

2020

Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.

Applications

Unspecified application

Species

Unspecified reactive species

Lina Schukur,Tamara Zimmermann,Ole Niewoehner,Grainne Kerr,Scott Gleim,Beatrice Bauer-Probst,Britta Knapp,Giorgio G Galli,Xiaoyou Liang,Angelica Mendiola,John Reece-Hoyes,Melivoia Rapti,Ines Barbosa,Markus Reschke,Thomas Radimerski,Claudio R Thoma

Acta neuropathologica communications 8:143 PubMed32825842

2020

Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Rachel E Lackie,Jose Marques-Lopes,Valeriy G Ostapchenko,Sarah Good,Wing-Yiu Choy,Patricija van Oosten-Hawle,Stephen H Pasternak,Vania F Prado,Marco A M Prado

Molecules (Basel, Switzerland) 25: PubMed32429462

2020

Green Tea Seed Isolated Theasaponin E1 Ameliorates AD Promoting Neurotoxic Pathogenesis by Attenuating Aβ Peptide Levels in SweAPP N2a Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Muhammad Imran Khan,Jin Hyuk Shin,Min Yong Kim,Tai Sun Shin,Jong Deog Kim

Neural regeneration research 14:1562-1572 PubMed31089055

2019

L-Norvaline, a new therapeutic agent against Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Baruh Polis,Kolluru D Srikanth,Vyacheslav Gurevich,Hava Gil-Henn,Abraham O Samson

Bratislavske lekarske listy 120:148-154 PubMed30793620

2019

Investigation of THDOC effects on pathophysiological signs of Alzheimer's disease as an endogenous neurosteroid: inhibition of acetylcholinesterase and plaque deposition.

Applications

Unspecified application

Species

Unspecified reactive species

H Saleh,L Sadeghi

Journal of Alzheimer's disease : JAD 66:1425-1435 PubMed30400087

2018

Phytochemicals from Achillea fragrantissima are Modulators of AβPP Metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Nancy Bartolotti,Ahmed Disouky,Arthur Kalinski,Anat Elmann,Orly Lazarov

Frontiers in neuroscience 12:647 PubMed30283295

2018

Fourier-Transform Infrared Imaging Spectroscopy and Laser Ablation -ICPMS New Vistas for Biochemical Analyses of Ischemic Stroke in Rat Brain.

Applications

Unspecified application

Species

Unspecified reactive species

Mohamed H M Ali,Fazle Rakib,Essam M Abdelalim,Andreas Limbeck,Raghvendra Mall,Ehsan Ullah,Nasrin Mesaeli,Donald McNaughton,Tariq Ahmed,Khalid Al-Saad
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com